ArticleScientific reports2026

Exploration of real-world outcomes in patients with previously treated HR+/HER2- and triple negative metastatic breast cancer.

Natalia Sadetsky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.